Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism.
Not Applicable
Terminated
- Conditions
- HTPPEIdiopathic Pulmonary Embolism
- Interventions
- Other: HTPPE
- Registration Number
- NCT01894204
- Lead Sponsor
- University Hospital, Brest
- Brief Summary
Forward-looking troop established(constituted) by the patients having been included in the study " PADIS EP ", PHRC on 2006 and 2009, randomized checked(controlled), double-blind, comparing an anticoagulating treatment(processing) extended by coumadine versus placebo during 18 months at patients having had a first episode of EP idiopathique treated(handled) initially 6 months by anti-vitamin K.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 235
Inclusion Criteria
- Patients having ended the study PADIS EP after the visit of the end of study and having signed the consent HTP.
Exclusion Criteria
- Refusal to grant in writing to participate in the study PADIS HTP
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description HTPPE HTPPE No drug and no placebo were used in this study. For all the patients who participated at the study PADIS-EP, somme exams must be performed.
- Primary Outcome Measures
Name Time Method Frequency of a HTPPE 24 months
- Secondary Outcome Measures
Name Time Method Mortality and cause 24 months
Trial Locations
- Locations (8)
CHRU de Brest
🇫🇷Brest, France
Hôpital Européen Georges Pompidou
🇫🇷Paris cedex 15, France
Hôpital Yves Le Foll
🇫🇷Saint-Brieuc, France
Hôpital Rangueuil
🇫🇷Toulouse, France
Hôpital de Bellevue - CHU de Saint-Etienne
🇫🇷Saint-Etienne, France
CH de Lannion
🇫🇷Lannion, France
CHU Pontchaillou - Hôpital Sud
🇫🇷Rennes, France
CHU Clermont-Ferrand
🇫🇷Clermont-Ferrand, France